Feed POLBF
PO

Poolbeg Pharma PLC

POLBF · OTC

$0.10 +0.00% (+$0.00)
Market Cap £54.2M
P/E Ratio -
Div. Yield -
ROE 53.90%
Piotroski F-Score Weak
1/9
Valuation
21 /100
Expensive
P/B 6.30x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining
Book val. growth 22.29%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A
Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor
ROIC 73.60%
ROE 53.90%
ROA 57.28%
Debt
100 /100
Low
Debt/Equity 0.00x
Current ratio 6.17x
Int. coverage N/A
Stability
27 /100
Unstable
Beta 1.81x
EPS volatility 37.15%
Profitable years 0

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o POLBF
Online

Sector

Healthcare

Industry

Biotechnology

CEO

Jeremy Skillington

Employees

15

Headquarters

London

Prihajajoči dogodki

04 MAR.

Earnings

Upcoming earnings report

164d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.